Product Information
METOCLOPRAMIDE 10 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0446 per EA under NDC 50228023305. Its NADAC has been published 42 times since Sep 10, 2025.
Strength
10 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228023305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA072215On Market Since
2/12/2025
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 10 MG TABLET has been published 42 times since Sep 10, 2025, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0446 per EA |
|---|---|
| All-time high | $0.0502 (Jan 14, 2026) |
| All-time low | $0.0440 (Apr 22, 2026) |
| 52-week high | $0.0502 |
| 52-week low | $0.0440 |
| Median price | $0.0494 |
| Average price | $0.0478 |
| Largest weekly change | -4.8% (Mar 18, 2026) |
| Weeks tracked | 42 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 10 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0446 per EA (NDC 50228023305), effective Jun 24, 2026.
How has the price of METOCLOPRAMIDE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 10 MG TABLET has declined 11.0%. It has been tracked across 42 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 10 MG TABLET?
Since Sep 10, 2025, the NADAC for METOCLOPRAMIDE 10 MG TABLET has ranged from a low of $0.0440 (Apr 22, 2026) to a high of $0.0502 (Jan 14, 2026), with a median of $0.0494 per EA.
Are there cheaper alternatives to METOCLOPRAMIDE 10 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as METOCLOPRAMIDE 10 MG TABLET, but none are currently priced below it.
Who manufactures METOCLOPRAMIDE 10 MG TABLET?
METOCLOPRAMIDE 10 MG TABLET (NDC 50228023305) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification